Climate Change Data

Environmental Metrics

ESG Focus Areas

• Transform patient lives
• Prioritize our people
• Conduct our business with integrity
• Address our environmental responsibilities
• Provide our products

Environmental Achievements

• At our FCP facility, a new cryogenic condenser achieved over 90% Volatile Organic Compounds (VOC) removal efficiency in its first full year of operation; improvements to the ventilation reduced our solvent emissions and help us to maintain our safe workplace exposure limits; and our implementation of a new process automation system has improved process efficiencies and waste control
• A new energy management system, ClearVUE Zero, provides granular per-second detail on our electricity use at our FCP and R&D facility in Hull, down to the circuit level. This data will inform our efforts to improve operational efficiency, reduce energy expenditure, and lower our carbon footprint
• Our FCP and R&D facility in Hull achieved a zero-landfill target with a comprehensive waste segregation program that enabled the diversion of waste away from landfill. The waste management disposal process ensured waste were disposed through recycling, aqueous waste treatment, waste to energy, and incineration (for clinical waste) as alternatives to landfill
• SUBLOCADE® packaging transition to smaller pack size reduced cardboard and foil packaging materials by 45%
• Reduced office-based employee commuting travel by up to 40% through hybrid work policies and technology

Social Achievements

• Expanded Culture and Inclusion network to progress efforts around diversity and inclusion and well-being
• Welcomed 160 new colleagues to the Company
• 87% of Indivior employees participated in a survey indicating that Indivior was a great place to work and they are passionate about Indivior’s mission
• Awarded the Great Place to Work® certification in seven countries
• Proportion of female Directors of Indivior PLC rose from 27% to 33%

Governance Achievements

• Implemented a global environmental management policy
• Revised and Updated Occupational Health and Safety Policy (2022)
• Implemented Indivior Global Integrity & Compliance Program (IGICP)
• Introduced an ESG metric for 2023 executive remuneration plans

Climate Goals & Targets

Environmental Challenges

• Ensuring access to affordable treatment for substance use disorder
• Reducing emissions
• Managing hazardous waste
• Transition risks (technology, policy and legal)
• Physical risks (acute risks to third-party facilities, risks to CMOs and CPOs)

Mitigation Strategies

• Long-term collaborations, Phase IV studies, real-world evidence studies, externally sponsored studies, label updates, peer-reviewed publications, and conference presentations to break down barriers to treatment access
• Implementing energy conservation measures, exploring renewable energy options, enhancing environmental reporting processes
• Implementing a global environmental management policy addressing water stewardship, biodiversity, responsible energy use, and efficient use of raw materials and waste minimization
• Flood prevention measures at the Fine Chemical Plant in Hull
• Developing robust ESG strategies to mitigate transition risks
• Developing further mitigations for physical risks

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Supplier Code of Conduct requiring responsible approach to environmental and climate change matters

Climate-Related Risks & Opportunities

Physical Risks

• Acute risks to physical third-party facilities from catastrophic storm events and increasing heat
• Risks to CMOs and CPOs (UK and U.S.) due to catastrophic storm events

Transition Risks

• Higher costs linked to technological transition to low carbon
• Higher costs and reputational risk due to increasing compliance regulations
• Compliance risk as regulations increase

Opportunities

• Reducing costs from shifting to low-emissions energy

Reporting Standards

Frameworks Used: TCFD, GRI, UN Global Compact, UN Sustainable Development Goals (SDGs)

Certifications: ISO 14001:2015 (Hull FCP), ISO 45001:2018 (Hull FCP)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Goal 3: Good Health and Well-being
• Goal 12: Responsible Consumption and Production
• Goal 13: Climate Action
• Goal 16: Peace, Justice and Strong Institutions
• Goal 5: Gender Equality

Indivior's activities align with these goals through its focus on addiction treatment, environmental responsibility, ethical business practices, and diversity and inclusion.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Great Place to Work® certification

Environmental Metrics

ESG Focus Areas

• Transform Patient Lives
• Prioritize Our People
• Conduct Our Business With Integrity
• Address Our Environmental Responsibilities
• Provide Our Products

Environmental Achievements

• Installed solar panels at the Hull Fine Chemical Plant (FCP), avoiding 6.353 tCO2e in GHG emissions and saving approximately $4,000 annually.
• Installed solar panels at the Chapleo location, generating 22,084 KWh of energy, reducing 1.9% of total consumption, and saving approximately $4,000 annually.
• Transitioned to more than 30 hybrid vehicles in the U.S. as part of a plan to achieve a 100% hybrid fleet by the end of 2026.
• Identified an initiative to switch to more sustainable carton packaging for SUBOXONE Film in the U.S., expected to reduce GHG emissions per carton by about 60% in 2024.

Social Achievements

• Increased patient access to SUBLOCADE by more than 66% year-over-year, helping over 136,000 patients.
• Launched OPVEE nasal spray for opioid overdose treatment.
• Expanded patient access to treatment options within criminal justice system facilities and through alternative sites of care (ASOC) with Albertsons.
• Launched the OPVEE Experience Program, partnering with law enforcement and community organizations to provide free OPVEE.
• Received “Great Place to Work” certification for the second year and was named to Fortune magazine’s “Best Workplaces in BioPharma™” list and the U.K.’s “Best Workplaces for Women™” list.

Governance Achievements

• Linked progress on sustainability-related initiatives to the annual incentive plan for all employees.
• Continued to assess environmental program as part of annual risk management process.
• Maintained a strong environmental safety record at FCP and Chapleo, both ISO 14001:2015 certified.
• High employee response rates in the annual Ethics & Compliance Program Perceptions Survey, exceeding industry benchmarks.

Climate Goals & Targets

Environmental Challenges

• Managing GHG emissions from production, including direct and indirect emissions from various sites and activities.
• Managing Scope 3 emissions related to purchased goods and services, capital goods, fuel and energy, waste, business travel, and end-of-life treatment of sold products.
• Predicting future emissions from the newly acquired Raleigh manufacturing facility.

Mitigation Strategies

• Strengthened oversight and management of GHG emissions, energy consumption, chemical use, and waste disposal.
• Initiated data collection and GHG estimations for Scope 3 emissions.
• Investing in solar capacity at the FCP to reduce environmental impact.
• Implementing a new U.S. hybrid fleet program.
• Evaluating ways to reduce manufacturing waste through sustainable packaging solutions.

Supply Chain Management

Supplier Audits: All new major suppliers are examined using social criteria and are required to adhere to Indivior’s Third-Party Code of Conduct.

Responsible Procurement

• Third-Party Code of Conduct requiring suppliers to address environmental and climate change issues.

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: GRI Standards, TCFD

Certifications: ISO 14001:2015 (FCP and Chapleo), ISO 45001:2018 (FCP and Hull R&D)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• More sustainable carton packaging for SUBOXONE Film (planned for 2024)

Awards & Recognition

• “Great Place to Work” certification
• Fortune Best Workplaces in BioPharma™
• U.K.’s Best Workplaces for Women™